OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Investigator: John Lisman

1 Projects | 1 Researchers | $461,910 Invested

2016

Brandeis University

John Lisman, PhD

Treatment strategies based on enhancing dopamine release from noradrenergic axons.

  • Funding Amount: $461,910
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Synaptic Activity and Neurotransmitters
  • Status: Closed